These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 6396733)
1. Inhibition of prostaglandin I2 (PGI2) formation by LDL-cholesterol or LDL-peroxides? Beitz J; Panse M; Fischer S; Hora C; Förster W Prostaglandins; 1983 Dec; 26(6):885-92. PubMed ID: 6396733 [TBL] [Abstract][Full Text] [Related]
2. Serum lipoproteins, lipid peroxides and prostacyclin biosynthesis in patients with coronary heart disease. Szczeklik A; Gryglewski RJ; Domagała B; Zmuda A; Hartwich J; Woźny E; Grzywacz M; Madej J; Gryglewska T Prostaglandins; 1981 Nov; 22(5):795-807. PubMed ID: 7036228 [TBL] [Abstract][Full Text] [Related]
3. Effect of HDL and LDL from pre and post menopausal women on prostacyclin synthesis. Beitz J; Müller G; Förster W Prostaglandins; 1985 Aug; 30(2):179-83. PubMed ID: 3901120 [TBL] [Abstract][Full Text] [Related]
4. Influence of a plasma fraction of human blood, rich in high density lipoprotein, on in vitro formation of prostaglandin I2 (PGI2) and thromboxane A2 (TXA2). Beitz J; Kuklinski B; Taube C; Mest HJ Prostaglandins Leukot Essent Fatty Acids; 1989 Jan; 35(1):37-9. PubMed ID: 2648415 [TBL] [Abstract][Full Text] [Related]
5. Stimulation and inhibition of PGI2 synthetase activity by phospholipids (PL), cholesterol esters (CE), unesterified fatty acids (UFA) and lipoproteins (LDL and HDL). Förster W; Beitz J; Hoffmann P Artery; 1980; 8(5):494-500. PubMed ID: 6783016 [TBL] [Abstract][Full Text] [Related]
6. Influence of human low density and high density lipoprotein cholesterol on the in vitro prostaglandin I2 synthetase activity. Beitz J; Förster W Biochim Biophys Acta; 1980 Dec; 620(3):352-5. PubMed ID: 6786342 [TBL] [Abstract][Full Text] [Related]
7. Differential influence of lipoproteins isolated from women and men on the activity of the PGI2 synthetase activity. Beitz J; Förster W Prostaglandins Med; 1981 May; 6(5):515-8. PubMed ID: 6791179 [TBL] [Abstract][Full Text] [Related]
8. Low density lipoproteins (LDL) are carriers for lipid peroxides and inhibit prostacyclin (PGI2) biosynthesis in arteries. Szczeklik A; Gryglewski RJ Artery; 1980; 7(6):488-95. PubMed ID: 7016082 [TBL] [Abstract][Full Text] [Related]
9. High density lipoprotein can modulate the inhibitory effect of oxLDL on prostacyclin generation by rat aorta in vitro. Mahfouz MM; Kummerow FA Prostaglandins Other Lipid Mediat; 2003 Nov; 72(3-4):91-114. PubMed ID: 14674623 [TBL] [Abstract][Full Text] [Related]
10. The influence of lipoproteins (LDL and HDL) on PGI2-formation by isolated aortic preparations of rabbits. Giessler C; Beitz J; Mentz P; Förster W Prostaglandins Leukot Med; 1986 May; 22(2):221-34. PubMed ID: 3523542 [TBL] [Abstract][Full Text] [Related]
11. Effect of human plasma lipoproteins on prostacyclin production by cultured endothelial cells. Spector AA; Scanu AM; Kaduce TL; Figard PH; Fless GM; Czervionke RL J Lipid Res; 1985 Mar; 26(3):288-97. PubMed ID: 3921636 [TBL] [Abstract][Full Text] [Related]
12. Conversions of prostaglandin endoperoxides by prostacyclin synthase from pig aorta. Wlodawer P; Hammarström S Prostaglandins; 1980 Jun; 19(6):969-76. PubMed ID: 6992239 [TBL] [Abstract][Full Text] [Related]
13. Low density lipoproteins of male donors decrease prostacyclin (PGI2) and enhance thromboxane (TXA2) release from rat aortas perfused under pulsatile pressure. Beitz J; Hoffmann P; Taube C; Beitz A; Förster W Biomed Biochim Acta; 1985; 44(11-12):1681-6. PubMed ID: 3911954 [TBL] [Abstract][Full Text] [Related]
14. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia. Yovos JG; Patel ST; Falko JM; Newman HA; Hill DS J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797 [TBL] [Abstract][Full Text] [Related]
15. Lipoprotein composition in NIDDM: effects of dietary oleic acid on the composition, oxidisability and function of low and high density lipoproteins. Dimitriadis E; Griffin M; Collins P; Johnson A; Owens D; Tomkin GH Diabetologia; 1996 Jun; 39(6):667-76. PubMed ID: 8781762 [TBL] [Abstract][Full Text] [Related]
16. [Effects of hyperlipidemic sera and lipoproteins on prostacyclin synthesis by rabbit aortic smooth muscle cells]. Hu YH; Wang Z Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Oct; 11(5):366-71. PubMed ID: 2534618 [TBL] [Abstract][Full Text] [Related]
17. Is the level of steroid hormones in the low density lipoprotein (LDL) particles responsible for the prostaglandin I2 inhibitory potency of LDL? Beitz J; Schollberg K; Fischer S; Jaross W; Hanefeld M; Mest HJ Biomed Biochim Acta; 1988; 47(2):181-7. PubMed ID: 3052442 [TBL] [Abstract][Full Text] [Related]
18. [Quantitative analysis of lipoproteins in hyperlipoproteinemias of type IIa, IIb and IV (author's transl)]. Loeper J; Goy-Loeper J; Rouffy J Clin Chim Acta; 1979 Oct; 98(1-2):19-26. PubMed ID: 227624 [TBL] [Abstract][Full Text] [Related]
19. Modification of prostacyclin-stimulatory activity in sera by glucose, insulin, low density lipoprotein, linoleic acid and linoleic acid hydroperoxide. Umeda F; Kunisaki M; Inoguchi T; Nawata H Diabetes Res Clin Pract; 1990 Jan; 8(2):137-44. PubMed ID: 2106424 [TBL] [Abstract][Full Text] [Related]
20. Fatty acid composition and action of serum lipoproteins on the PGI2-formation after various oil diets in hyperlipoproteinemia. Honigmann G; Schimke E; Schliack V; Beitz J; Förster W; Fischer S; Hora C; Hanefeld M Biomed Biochim Acta; 1984; 43(8-9):S443-6. PubMed ID: 6393974 [No Abstract] [Full Text] [Related] [Next] [New Search]